In AML there is evidence of a coordinated alterations in IDH2 (epigenetic regulator) and SRSF2 (splicing factor), resulting in distinct splicing changes and increased stalling of RNA polymerase II [51]. The gene discussed is SRSF2; the disease is acute myeloid leukemia.